Chemoinformaics analysis of 2-(4-methylcyclohex-2-en-1-yl)propan-2-yl Acetate
Molecular Weight | 196.29 | nRot | 2 |
Heavy Atom Molecular Weight | 176.13 | nRig | 7 |
Exact Molecular Weight | 196.146 | nRing | 1 |
Solubility: LogS | -2.97 | nHRing | 0 |
Solubility: LogP | 3.676 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 34.9799 |
nHD | 0 | BPOL | 22.6681 |
QED | 0.501 |
Synth | 3.93 |
Natural Product Likeliness | 2.486 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.008 |
Pgp-sub | 0.001 |
HIA | 0.006 |
CACO-2 | -4.427 |
MDCK | 0.0000247 |
BBB | 0.981 |
PPB | 0.93054 |
VDSS | 1.461 |
FU | 0.163871 |
CYP1A2-inh | 0.238 |
CYP1A2-sub | 0.205 |
CYP2c19-inh | 0.079 |
CYP2c19-sub | 0.84 |
CYP2c9-inh | 0.133 |
CYP2c9-sub | 0.334 |
CYP2d6-inh | 0.023 |
CYP2d6-sub | 0.497 |
CYP3a4-inh | 0.168 |
CYP3a4-sub | 0.364 |
CL | 4.746 |
T12 | 0.413 |
hERG | 0.007 |
Ames | 0.007 |
ROA | 0.015 |
SkinSen | 0.079 |
Carcinogencity | 0.207 |
EI | 0.958 |
Respiratory | 0.232 |
NR-Aromatase | 0.003 |
Antiviral | No |
Prediction | 0.529458 |